Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
37.86
-0.01 (-0.03%)
Aug 13, 2025, 4:00 PM - Market closed
Collegium Pharmaceutical Employees
Collegium Pharmaceutical had 357 employees as of December 31, 2024. The number of employees increased by 160 or 81.22% compared to the previous year.
Employees
357
Change (1Y)
160
Growth (1Y)
81.22%
Revenue / Employee
$1,980,412
Profits / Employee
$101,599
Market Cap
1.19B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
COLL News
- 6 days ago - Collegium Pharmaceutical, Inc. (COLL) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Collegium Reports Second Quarter 2025 Financial Results; Raises 2025 Outlook - GlobeNewsWire
- 21 days ago - Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025 - GlobeNewsWire
- 5 weeks ago - Collegium Announces $150 Million Share Repurchase Program - GlobeNewsWire
- 6 weeks ago - Collegium Pharmaceutical: Stock Deserves A "Buy" Call On Undervaluation Of ADHD Drug - Seeking Alpha
- 3 months ago - Collegium to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Collegium Announces $25 Million Accelerated Share Repurchase Program - GlobeNewsWire
- 3 months ago - Collegium Pharmaceutical, Inc. (COLL) Q1 2025 Earnings Call Transcript - Seeking Alpha